探讨CLAG(克拉屈滨、阿糖胞苷、G-CSF)±地西他滨(DAC)方案对难治复发性急性髓系白血病(R/R AML)的疗效及其影响因素。. This evidence concerns the gene CSF3 and acute myeloid leukemia.